Plasma proteomics shows an elevation of the anti-inflammatory protein APOA-IV in chronic equine laminitis

BMC Veterinary Research

Volumn 8, Issue , 2012, Pages

  Steelman, Samantha M ^a   Chowdhary, Bhanu P ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EQUIDAE;

APOLIPOPROTEIN A; TRANSCRIPTOME;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BLOOD CLOTTING; CHRONIC DISEASE; FEMALE; FOOT DISEASE; GENE EXPRESSION REGULATION; GENETICS; HOOF AND CLAW; HORSE; HORSE DISEASE; INFLAMMATION; MALE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEOMICS;

ANIMALS; APOLIPOPROTEINS A; BLOOD COAGULATION; CHRONIC DISEASE; FEMALE; FOOT DISEASES; GENE EXPRESSION REGULATION; HOOF AND CLAW; HORSE DISEASES; HORSES; INFLAMMATION; MALE; PROTEOMICS; TRANSCRIPTOME;

EID: 84866696989     PISSN: None     EISSN: 17466148     Source Type: Journal    
DOI: 10.1186/1746-6148-8-179     Document Type: Article

References (49)

1. Slater MR, Hood DM, Carter GK. Descriptive epidemiological study of equine laminitis. Equine Vet J 1995, 27(5):364-367.
2. USDA Lameness & laminitis in U.S. horses 2000, Fort Collins, Service APHI, USDA.
3. Pollitt CC. Basement membrane pathology: a feature of acute equine laminitis. Equine Vet J 1996, 28(1):38-46.
4. Moore RM. Vision 20/20 - conquer laminitis by 2020. J Eq Vet Sci 2010, 30(2):74-76.
5. Faleiros RR, Stokes AM, Eades SC, Kim DY, Paulsen DB, Moore RM. Assessment of apoptosis in epidermal lamellar cells in clinically normal horses and those with laminitis. Am J Vet Res 2004, 65(5):578-585.
6. Johnson PJ, Ganjam VK, Slight SH, Kreeger JM, Messer NT. Tissue-specific dysregulation of cortisol metabolism in equine laminitis. Equine Vet J 2004, 36(1):41-45.
7. Kuwano A, Ueno T, Katayama Y, Nishiyama T, Arai K. Unilateral basement membrane zone alteration of the regenerated laminar region in equine chronic laminitis. J Vet Med Sci 2005, 67(7):685-691.
8. Carter RA, Engiles JB, Megee SO, Senoo M, Galantino-Homer HL. Decreased expression of p63, a regulator of epidermal stem cells, in the chronic laminitic equine hoof. Equine veterinary journal 2011, 43(5):543-551.
9. Guedes AG, Matthews NS, Hood DM. Effect of ketamine hydrochloride on the analgesic effects of tramadol hydrochloride in horses with signs of chronic laminitis-associated pain. American journal of veterinary research 2012, 73(5):610-619.
10. Ramsey GD, Hunter PJ, Nash MP. The effect of hoof angle variations on dorsal lamellar load in the equine hoof. Equine veterinary journal 2011, 43(5):536-542.
11. Jones E, Vinuela-Fernandez I, Eager RA, Delaney A, Anderson H, Patel A, Robertson DC, Allchorne A, Sirinathsinghji EC, Milne EM, et al. Neuropathic changes in equine laminitis pain. Pain 2007, 132(3):321-331.
12. Wagner IP, Rees CA, Dunstan RW, Credille KM, Hood DM. Evaluation of systemic immunologic hyperreactivity after intradermal testing in horses with chronic laminitis. Am J Vet Res 2003, 64(3):279-283.
13. Hood DM. Laminitis as a systemic disease. Vet Clin North Am Equine Pract 1999, 15(2):481-494. viii.
14. Lee C, Bongcam-Rudloff E, Sollner C, Jahnen-Dechent W, Claesson-Welsh L. Type 3 cystatins; fetuins, kininogen and histidine-rich glycoprotein. Front Biosci 2009, 14:2911-2922.
15. Olivier E, Soury E, Ruminy P, Husson A, Parmentier F, Daveau M, Salier JP. Fetuin-B, a second member of the fetuin family in mammals. Biochem J 2000, 350(Pt 2):589-597.
16. Stan S, Delvin E, Lambert M, Seidman E, Levy E. Apo A-IV: an update on regulation and physiologic functions. Biochim Biophys Acta 2003, 1631(2):177-187.
17. Juneja RK, Gahne B, Lukka M, Ehnholm C. A previously reported polymorphic plasma protein of dogs and horses, identified as apolipoprotein A-IV. Anim Genet 1989, 20(1):59-63.
18. Gandhi KS, McKay FC, Diefenbach E, Crossett B, Schibeci SD, Heard RN, Stewart GJ, Booth DR, Arthur JW. Novel approaches to detect serum biomarkers for clinical response to interferon-beta treatment in multiple sclerosis. PLoS One 2010, 5(5):e10484.
19. Ho AS, Cheng CC, Lee SC, Liu ML, Lee JY, Wang WM, Wang CC. Novel biomarkers predict liver fibrosis in hepatitis C patients: alpha 2 macroglobulin, vitamin D binding protein and apolipoprotein AI. J Biomed Sci 2010, 17:58.
20. Lu Y, Liu J, Lin C, Wang H, Jiang Y, Wang J, Yang P, He F. Peroxiredoxin 2: a potential biomarker for early diagnosis of hepatitis B virus related liver fibrosis identified by proteomic analysis of the plasma. BMC Gastroenterol 2010, 10:115.
21. Dowling P, O'Driscoll L, Meleady P, Henry M, Roy S, Ballot J, Moriarty M, Crown J, Clynes M. 2-D difference gel electrophoresis of the lung squamous cell carcinoma versus normal sera demonstrates consistent alterations in the levels of ten specific proteins. Electrophoresis 2007, 28(23):4302-4310.
22. Gourin CG, Zhi W, Adam BL. Proteomic identification of serum biomarkers for head and neck cancer surveillance. Laryngoscope 2009, 119(7):1291-1302.
23. Ma Y, Peng J, Huang L, Liu W, Zhang P, Qin H. Searching for serum tumor markers for colorectal cancer using a 2-D DIGE approach. Electrophoresis 2009, 30(15):2591-2599.
24. Rodriguez-Pineiro AM, Blanco-Prieto S, Sanchez-Otero N, Rodriguez-Berrocal FJ, de la Cadena MP. On the identification of biomarkers for non-small cell lung cancer in serum and pleural effusion. J Proteomics 2010, 73(8):1511-1522.
25. Rong Y, Jin D, Hou C, Hu J, Wu W, Ni X, Wang D, Lou W. Proteomics analysis of serum protein profiling in pancreatic cancer patients by DIGE: up-regulation of mannose-binding lectin 2 and myosin light chain kinase 2. BMC Gastroenterol 2010, 10:68.
26. Zipplies JK, Hauck SM, Schoeffmann S, Amann B, Stangassinger M, Ueffing M, Deeg CA. Serum PEDF levels are decreased in a spontaneous animal model for human autoimmune uveitis. J Proteome Res 2009, 8(2):992-998.
27. Zipplies JK, Hauck SM, Schoeffmann S, Amann B, van der Meijden CH, Stangassinger M, Ueffing M, Deeg CA. Kininogen in autoimmune uveitis: decrease in peripheral blood stream versus increase in target tissue. Invest Ophthalmol Vis Sci 2010, 51(1):375-382.
28. Choi JW, Wang X, Joo JI, Kim DH, Oh TS, Choi DK, Yun JW. Plasma proteome analysis in diet-induced obesity-prone and obesity-resistant rats. Proteomics 2010, 10(24):4386-4400.
29. Darde VM, de la Cuesta F, Dones FG, Alvarez-Llamas G, Barderas MG, Vivanco F. Analysis of the plasma proteome associated with acute coronary syndrome: does a permanent protein signature exist in the plasma of ACS patients?. J Proteome Res 2010, 9(9):4420-4432.
30. Soares AJ, Santos MF, Trugilho MR, Neves-Ferreira AG, Perales J, Domont GB. Differential proteomics of the plasma of individuals with sepsis caused by Acinetobacter baumannii. J Proteomics 2009, 73(2):267-278.
31. Ramadori G, Sipe JD, Dinarello CA, Mizel SB, Colten HR. Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med 1985, 162(3):930-942.
32. Bauer J, Weber W, Tran-Thi TA, Northoff GH, Decker K, Gerok W, Heinrich PC. Murine interleukin 1 stimulates alpha 2-macroglobulin synthesis in rat hepatocyte primary cultures. FEBS Lett 1985, 190(2):271-274.
33. Ron D, Brasier AR, Wright KA, Habener JF. The permissive role of glucocorticoids on interleukin-1 stimulation of angiotensinogen gene transcription is mediated by an interaction between inducible enhancers. Mol Cell Biol 1990, 10(8):4389-4395.
34. Doutremepuich C, Lalanne MC, Doutremepuich F, Francois C, Dosque JP, Sassoust G. Could non steroidal anti-inflammatory drugs be used to potentiate L.M.W.H activity in thrombosis? (Part I). Thromb Res 1991, 63(1):13-19.
35. Apfelbaum TF, Davidson NO, Glickman RM. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am J Physiol 1987, 252(5 Pt 1):G662-G666.
36. Fujimoto K, Fukagawa K, Sakata T, Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J Clin Invest 1993, 91(4):1830-1833.
37. Qin X, Swertfeger DK, Zheng S, Hui DY, Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am J Physiol 1998, 274(5 Pt 2):H1836-H1840.
38. Vowinkel T, Mori M, Krieglstein CF, Russell J, Saijo F, Bharwani S, Turnage RH, Davidson WS, Tso P, Granger DN, et al. Apolipoprotein A-IV inhibits experimental colitis. J Clin Invest 2004, 114(2):260-269.
39. Nerstedt A, Nilsson EC, Ohlson K, Hakansson J. Thomas Svensson L, Lowenadler B, Svensson UK, Mahlapuu M: Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. Br J Nutr 2007, 97(6):1117-1127.
40. Milinovich GJ, Klieve AV, Pollitt CC, Trott DJ. Microbial events in the hindgut during carbohydrate-induced equine laminitis. Vet Clin North Am Equine Pract 2010, 26(1):79-94.
41. Nabity MB, Lees GE, Dangott LJ, Cianciolo R, Suchodolski JS, Steiner JM. Proteomic analysis of urine from male dogs during early stages of tubulointerstitial injury in a canine model of progressive glomerular disease. Vet Clin Pathol 2011, 40(2):222-236.
42. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002, 74(20):5383-5392.
43. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003, 75(17):4646-4658.
44. Vizcaino JA, Cote R, Reisinger F, Barsnes H, Foster JM, Rameseder J, Hermjakob H, Martens L. The Proteomics Identifications database: 2010 update. Nucleic acids research 2010, 38(Database issue):D736-D742.
45. Dennis G. Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3.
46. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature protocols 2009, 4(1):44-57.
47. da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic acids research 2009, 37(1):1-13.
48. Rasband WS. ImageJ 1997-2011, U.S National Institutes of Health, Bethesda, MD.
49. Beisiegel U, Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem 1979, 93(3):601-608.